Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report

Amano,Yasuaki; Mandai,Masaki; Baba,Tsukasa; Hamanishi,Junzo; Yoshioka,Yumiko; Matsumura,Noriomi; Konishi,Ikuo

doi:10.3892/ol.2013.1530

Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report

Authors:
- Yasuaki Amano
- Masaki Mandai
- Tsukasa Baba
- Junzo Hamanishi
- Yumiko Yoshioka
- Noriomi Matsumura
- Ikuo Konishi
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto 606‑8507, Japan
Published online on: August 16, 2013 https://doi.org/10.3892/ol.2013.1530
Pages: 1241-1244

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The current study presents the case of a patient with a recurrent carcinoid tumor of the ovary, 13‑years after the primary surgery. The primary surgery consisted of a total abdominal hysterectomy and bilateral salpingo‑oophorectomy for a left ovarian tumor at 54 years old. Pathologically, the tumor was diagnosed as a carcinoid tumor of the ovary. Following the primary treatment, the patient was admitted to a cardiologist due to carcinoid‑induced heart failure. At 67 years old, the patient was referred to Kyoto University Hospital with a solitary mass 8 cm in diameter and located in the paraaortic area, which was detected by routine ultrasonography and subsequent computed tomography (CT) scans. Urinary 5‑hydroxyindole acetate (5‑HIAA), a serotonin degradation metabolite, was present at elevated levels. With a diagnosis of a recurrent carcinoid tumor, the patient underwent a tumor resection. The pathological diagnosis was that of lymph node metastasis of the trabecular carcinoid. Post‑operatively, the 5‑HIAA levels returned to normal. Carcinoid tumors occasionally recur following surgery due to borderline malignant potential. Due to the slow growing nature of these tumors, in specific cases, recurrence occurs following a long interval. Therefore, a relatively long follow‑up period is required.

View Figures

View References

1	Fox DJ and Khattar RS: Carcinoid heart disease: presentation, diagnosis, and management. Heart. 90:1224–1228. 2004. View Article : Google Scholar : PubMed/NCBI
2	Palaniswamy C, Frishman WH and Aronow WS: Carcinoid heart disease. Cardiol Rev. 20:167–176. 2012. View Article : Google Scholar
3	Lundin L, Norheim I, Landelius J, Oberg K and Theodorsson-Norheim E: Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation. 77:264–269. 1988. View Article : Google Scholar
4	Stewart MJ, Willis RA and De Saram GS: Argentaffine carcinoma (carcinoid tumour) arising in ovarian teratomas: A report of two cases. J Pathol Bacteriol. 49:207–212. 1939. View Article : Google Scholar
5	Bai X, Li N, Wang F, Li S and Yu Q: Primary ovarian trabecular carcinoid tumor: a case report and literature review. Arch Gynecol Obstet. 282:407–411. 2010. View Article : Google Scholar : PubMed/NCBI
6	Talerman A: Carcinoid tumors of the ovary. J Cancer Res Clin Oncol. 107:125–135. 1984. View Article : Google Scholar
7	Díaz-Montes TP, Rosenthal LE, Bristow RE and Grumbine FC: Primary insular carcinoid of the ovary. Gynecol Oncol. 101:175–178. 2006.
8	Timmins PF, Kuo DY, Anderson PS, Fields AL, Whitney KD and Goldberg GL: Ovarian carcinoid: management of primary and recurrent tumors. Gynecol Oncol. 76:112–114. 2000. View Article : Google Scholar : PubMed/NCBI
9	Chaowalit N, Connolly HM, Schaff HV, Webb MJ and Pellikka PA: Carcinoid heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol. 93:1314–1315. 2004. View Article : Google Scholar : PubMed/NCBI
10	Moerman VM, Dewilde D and Hermans K: Carcinoid heart disease: typical findings on echocardiography and cardiac magnetic resonance. Acta Cardiol. 67:245–248. 2012.PubMed/NCBI
11	Garg S, Bourantas CV, Nair RK and Alamgir F: Carcinoid syndrome diagnosed by echocardiography. Int J Cardiol. 147:e1–e3. 2011. View Article : Google Scholar : PubMed/NCBI
12	Hong SN, Saric M and Kronzon I: Carcinoid heart disease. J Am Coll Cardiol. 55:19962010. View Article : Google Scholar
13	van der Horst-Schrivers AN, Post WJ, et al: Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours. Eur J Cancer. 43:2651–2657. 2007.PubMed/NCBI
14	Robiolio PA, Rigolin VH, Wilson JS, et al: Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 92:790–795. 1995. View Article : Google Scholar
15	Buda A, Giuliani D, Montano N, Perego P and Milani R: Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case. Int J Surg Case Rep. 3:59–61. 2012. View Article : Google Scholar : PubMed/NCBI
16	Seregni E, Ferrari L, Bajetta E, Martinetti A and Bombardieri E: Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol. 12(Suppl 2): S69–S72. 2001. View Article : Google Scholar : PubMed/NCBI
17	Klöppel G, Couvelard A, Perren A, et al: ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 90:162–166. 2009.
18	Sundin A, Vullierme MP, Kaltsas G and Plöckinger U: Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society: ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations. Neuroendocrinology. 90:167–183. 2009. View Article : Google Scholar